Anwita is Client –focused organization offering CRAMS (Contract Research and Manufacturing Services) and integrated portfolio of products to the global pharmaceuticals industry. Anwita involved in development of branded generics, regulated generics, NDDS (Novel Drug Delivery Systems) formulations and client –focused drug product development . aims to fortify technical support to global pharmaceuticals industry, who are looking for marketing authorizations in global regulated markets.

We support customers with our unique value, extensive product range and global network of associates.

Philosophy

Focus on niche product manufacturing platforms, combining cutting-edge technology and the best minds in the business.

Quality 

Quality has always been a strong part of Anwita’s proposition. Our quality initiative covers all aspects including product quality, operational quality and environmental quality.

Vision

To provide integrated model gives our customer cost effective and efficient manner

Mission

Anwita is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains.

• Generic Drug Development for Solids, liquids, semi-solids, parenteral dosage forms. 
• Development of  Para-IV filing dosage forms with patent evaluation
• Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) formulations developments  
• NCE formulations development
• NCE Analytical Development
• Non-Infringing patent formulations and Patent evaluation.
• Pre-formulations and compatibility studies
• Dosage form development and Optimization ( NCE  and General APIs)
• Stability studies as per all ICH Zones ( Zone I,II, III, IVa, IVb)
• Dissolution and Impurity profiling
• Analytical Development and validations
• Advance drug delivery systems (Sustained, Extended, Delayed,  Nasal drug delivery, pulmonary drug delivery, etc)
• Dossier development and technology transfer
• Solubility enhancing technology for BCS class: II and IV  compounds